Bristol-Myers Squibb Company PFD CONV 2
BMYMP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9 | $8 | $6 | $7 |
| Dep. & Amort. | $10 | $10 | $10 | $11 |
| Deferred Tax | -$2 | -$3 | -$3 | -$1 |
| Stock-Based Comp. | $1 | $1 | $0 | $1 |
| Change in WC | $1 | -$2 | -$2 | -$1 |
| Other Non-Cash | $15 | $1 | $1 | $1 |
| Operating Cash Flow | $15 | $14 | $13 | $16 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$1 | -$1 |
| Net Acquisitions | -$21 | -$0 | -$3 | -$1 |
| Inv. Purchases | -$1 | -$2 | -$4 | -$5 |
| Inv. Sales/Matur. | $1 | $1 | $7 | $7 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$21 | -$2 | -$1 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $10 | $0 | -$5 | -$6 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$5 | -$8 | -$6 |
| Dividends Paid | -$5 | -$5 | -$5 | -$4 |
| Other Fin. Act. | -$0 | $0 | $1 | $1 |
| Financing Cash Flow | $5 | -$9 | -$17 | -$16 |
| Forex Effect | -$0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | -$1 | $2 | -$5 | -$1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12 | $9 | $14 | $15 |
| End Cash | $10 | $12 | $9 | $14 |
| Free Cash Flow | $14 | $13 | $12 | $15 |